CANNABIDIOL AND AGGRESSIVE BEHAVIOR

Long-term single housing increases aggressive behavior in mice, a condition named isolation-induced aggression or territorial aggression, which can be attenuated by anxiolytic, antidepressant, and antipsychotic drugs. Preclinical and clinical findings indicate that cannabidiol has anxiolytic, antidepressant, and antipsychotic properties.


Few studies, however, have investigated the effects of CBD on aggressive behaviors. Here, we investigated whether CBD could attenuate social isolation-induced aggressive behavior in the resident-intruder test. Male Swiss mice were single-housed for 10 days (resident mice) to induce aggressive behaviors, while conspecific mice of same sex and age (intruder mice) were group-housed. During the test, the intruder was placed into the resident's home-cage and aggressive behaviors initiated by the resident, including the latency for the first attack, number of attacks, and total duration of aggressive encounters, were recorded.

The involvement of 5-HT1A and CB1 receptors (CB1R) in the effects of CBD was also investigated. All tested CBD doses induced anti-aggressive effects, indicated by a decrease in the number of attacks. CBD, at intermediary doses, also increased latency to attack the intruder and decreased the duration of aggressive encounters. No CBD dose interfered with locomotor behavior. CBD anti-aggressive effects were attenuated by the 5-HT1A receptor antagonist WAY100635 and the CB1 antagonist AM25, suggesting that CBD decreases social isolation-induced aggressive behaviors through a mechanism associated with the activation of 5-HT1A and CB1 receptors. Also, CBD decreased c-Fos protein expression, a neuronal activity marker, in the lateral periaqueductal gray (lPAG) in social-isolated mice exposed to the resident-intruder test, indicating a potential involvement of this brain region in the drug effects.

Taken together, our findings suggest that CBD may be therapeutically useful to treat aggressive behaviors that are usually associated with psychiatric disorders.

https://www.ncbi.nlm.nih.gov/pubmed/31054943

FDA disclaimers apply to our products. This information is for general purposes only.
Older Post
Newer Post

Leave a comment

Please note, comments must be approved before they are published

Close (esc)

THE UNCANNA NEWSLETTER

UPDATES AND PROMOTIONS | DON'T MISS OUT

Age verification

By clicking enter you are verifying that you are old enough to consume alcohol.

Search

Shopping Cart

Your cart is currently empty.
Shop now